<DOC>
	<DOCNO>NCT01412047</DOCNO>
	<brief_summary>How long term treatment Soliris affect HAHA PNH patient ?</brief_summary>
	<brief_title>Paroxysmal Nocturnal Hemoglobinuria Human Anti-Human Antibodies Study</brief_title>
	<detailed_description>To determine long term effect Soliris ( eculizumab ) treatment presence human anti-human antibody ( HAHA ) Paroxysmal Nocturnal Hemoglobinuria ( PNH ) patient .</detailed_description>
	<mesh_term>Hemoglobinuria , Paroxysmal</mesh_term>
	<mesh_term>Hemoglobinuria</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>PNH patient previously participate study E05001 ; Patients eculizumab naive serum sample comparison ; Patients currently use commerical Soliris ; Patients willing able gie write informed consent . There exclusion criterion study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Paroxysmal Nocturnal Hemoglobinuria</keyword>
	<keyword>PNH</keyword>
	<keyword>Human Anti-Human Antibody</keyword>
	<keyword>HAHA</keyword>
	<keyword>Soliris</keyword>
	<keyword>eculizumab</keyword>
</DOC>